Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World ...

Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Early Access Programs (EAPs) and Named Patient Programs (NPPs) provide a pathway for patients with life-threatening ...

Shattuck Labs is reducing its workforce by 40%, bringing its employee count below 50, and discontinuing its SL-172154 program ...

The US Food and Drug Administration (FDA) yesterday released its fiscal year 2023 (FY23) Generic Drug User Fee Amendments ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...